Solid Biosciences Inc at Citi BioPharma Conference Transcript - Thomson StreetEvents

Solid Biosciences Inc at Citi BioPharma Conference Transcript

Solid Biosciences Inc at Citi BioPharma Conference Transcript - Thomson StreetEvents
Solid Biosciences Inc at Citi BioPharma Conference Transcript
Published Sep 07, 2023
11 pages (7908 words) — Published Sep 07, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of SLDB.OQ presentation 7-Sep-23 1:40pm GMT

  
Brief Excerpt:

...Max Riso So good morning, everyone. Thanks for joining us this morning at the Citi Healthcare Conference. Max Riso here with the Citi Healthcare Investment Banking team. Very excited this morning to have with us Bo Cumbo, CEO of Solid Biosciences joining us. Solid Biosciences is advancing a portfolio of neuromuscular and cardiac programs, including SGT-003, the differentiated gene transfer candidate for the treatment of Duchenne Muscular Dystrophy; AVB-202, a gene therapy treatment for the treatment of Friedreich's Ataxia; AVB-401, a gene therapy program for the treatment of BAG3-mediated dilated cardiomyopathy and additional cardio assets. Look forward to having Bo with us, and I will pass the mic over to Bo. Thank you, Bo. Alexander G. Cumbo ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Solid Biosciences Inc
Ticker
SLDB.OQ
Time
1:40pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Solid Biosciences Inc at JPMorgan Healthcare Conference Transcript – 2024-01-11 – US$ 54.00 – Edited Transcript of SLDB.OQ presentation 11-Jan-24 5:45pm GMT

Solid Biosciences Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript – 2023-05-24 – US$ 54.00 – Edited Transcript of SLDB.OQ presentation 24-May-23 3:30pm GMT

Solid Biosciences Inc at JMP Securities Life Sciences Conference Transcript – 2023-05-15 – US$ 54.00 – Edited Transcript of SLDB.OQ presentation 15-May-23 5:00pm GMT

Solid Biosciences Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) Transcript – 2023-04-24 – US$ 54.00 – Edited Transcript of SLDB.OQ presentation 24-Apr-23 6:00pm GMT

Solid Biosciences Inc at Needham Healthcare Conference (Virtual) Transcript – 2023-04-20 – US$ 54.00 – Edited Transcript of SLDB.OQ presentation 20-Apr-23 12:00pm GMT

Solid Biosciences Inc at BMO Capital Markets BioPharma Spotlight Series: Genetic Medicine Delivery (Virtual) Transcript – 2023-03-28 – US$ 54.00 – Edited Transcript of SLDB.OQ presentation 28-Mar-23 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Solid Biosciences Inc at Citi BioPharma Conference Transcript" Sep 07, 2023. Alacra Store. May 19, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Solid-Biosciences-Inc-at-Citi-BioPharma-Conference-T15715778>
  
APA:
Thomson StreetEvents. (2023). Solid Biosciences Inc at Citi BioPharma Conference Transcript Sep 07, 2023. New York, NY: Alacra Store. Retrieved May 19, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Solid-Biosciences-Inc-at-Citi-BioPharma-Conference-T15715778>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.